Information and communication

It is NattoPharma's policy that all shareholders shall be treated equally as far as access to information relevant to evaluating and valuing the company is concerned, and that the company will receive and evaluate the shareholders' points of view and interest in the company's operations, result and strategies. NattoPharma strives to present accounts and other financial reporting in which investors can have full confidence and which satisfy the requirements of the Oslo Stock Exchange for listed companies. NattoPharma's accounting practices indicate a high degree of transparency and are based on the IFRS standard. Up-to-date financial information and other company related information is published on the company's website.

The company has not adopted guidelines for the company's contact with shareholders outside the annual general meeting, but is working on establishing these.

A financial calendar is available on the Company’s web-site.

Information sent to the shareholders is simultaneously posted on the Company’s web-site.

Contact Us

For more information, please visit our profile on the Oslo Stock Exchange website or contact:

Kjetil Ramsøy
Tel: (+47) 906 12 943

NattoPharma contact information:
Main Office: Kirkeveien 59B NO-1363 Høvik,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: